Depression and risk of cancer progression: An elusive link

Journal of Clinical Oncology

Volumn 25, Issue 17, 2007, Pages 2343-2344

  Irwin, Michael R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; DEPRESSION; EDITORIAL; FOLLOW UP; HUMAN; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL TIME; SYMPTOM; VALIDATION PROCESS;

DEPRESSION; DISEASE PROGRESSION; HUMANS; NEOPLASMS;

EID: 34347264911     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.10.7292     Document Type: Editorial

References (23)

1. Persky W, Kempthorne-Rawson J, Shekelle RB: Personality and risk of cancer: 20-year follow-up of the Western Electric Study. Psychosom Med 49:435-449, 1987
2. Shekelle RB, Raynor WJ, Ostfeld AM, et al: Psychological depression and 17-year risk of death from cancer. Psychosom Med 43:117-125, 1981
3. Frasure-Smith N, Lesperance F, Irwin MR, et al: Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes. Biol Psychiatry [epub ahead of print on January 6, 2007]
4. Zonderman A, Costa P, McCrae R: Depression as a risk for cancer morbidity and mortality in a nationally representative sample. JAMA 262:1191-1195, 1989
5. McGee R, Williams S, Elwood M: Depression and the development of cancer: A meta-analysis. Soc Sci Med 38:187-192, 1994
6. Linkins RW, Comstock GW: Depressed mood and development of cancer. Am J Epidemiol 132:962-972, 1990
7. Penninx BW, Guralnik JM, Pahor M, et al: Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst 90:1888-1893, 1998
8. Spiegel D, Giese-Davis J: Depression and cancer: Mechanisms and disease progression. Biol Psychiatry 54:269-282, 2003
9. Loberiza FR Jr, Rizzo JD, Bredeson CN, et al: Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol 20:2118-2126, 2002
10. Raison CL, Capuron L, Miller AH: Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol 27:24-31, 2006
11. Steel JL, Geller DA, Gamblin TC, et al: Depression, immunity, and survival in patients with hepatobiliary carcinoma. J Clin Oncol 25:2397-2405, 2007
12. Irwin MR, Miller AG: Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun 21:274-383, 2007
13. Lutgendorf SK, Sood AK, Anderson B, et al: Social support, psychological distress, and natural killer cell activity in ovarian cancer. J Clin Oncol 23:7105-7113, 2005
14. Melamed R, Rosenne E, Shakhar K, et al: Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: Suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain Behav Immun 19:114-126, 2005
15. Irwin M, Clark C, Kennedy B, et al: Nocturnal catecholamines and immune function in insomniacs, depressed patients, and control subjects. Brain Behav Immun 17:365-372, 2003
16. Thaker PH, Han LY, Kamat AA, et al: Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 12:939-944, 2006
17. Antoni MH, Lutgendorf SK, Cole SW, et al: The influence of bio-behavioural factors on tumour biology: Pathways and mechanisms. Nat Rev Cancer 6:240-248, 2006
18. Fawzy FI, Fawzy NW, Hyun CS, et al: Malignant melanoma: Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 50:681-689, 1993
19. Fawzy FI, Cousins N, Fawzy NW, et al: A structured psychiatric intervention for cancer patients: I. Changes over time in methods of coping and affective disturbance. Arch Gen Psychiatry 47:720-725, 1990
20. Fawzy FI, Kemeny ME, Fawzy NW, et al: A structured psychiatric intervention for cancer patients: II. Changes over time in immunological measures. Arch Gen Psychiatry 47:729-735, 1990
21. Fawzy FI, Canada AL, Fawzy NW: Malignant melanoma: Effects of a brief, structured psychiatric intervention on survival and recurrence at 10-year follow-up. Arch Gen Psychiatry 60:100-103, 2003
22. Williams S, Dale J: The effectiveness of treatment for depression/depressive symptoms in adults with cancer: A systematic review. Br J Cancer 94:372-390, 2006
23. Musselman DL, Lawson DH, Gumnick JF, et al: Paroxetine for the prevention of depression induced by high-dose interferon-alfa. N Engl J Med 344:961-966, 2001